Vigdis Bjerkeli

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Gut microbiota derived indoles are altered and associate with immune activation in moderate and severe carotid stenosis.

Gut microbiota derived indoles are altered and associate with immune activation in moderate and severe carotid stenosis.

Journal: Frontiers in immunology

Published: January 26, 2026

Plasma levels of soluble Flt-1 and Tie-2 correlate with neovascularization in human carotid atherosclerotic plaques - a pilot study.

Plasma levels of soluble Flt-1 and Tie-2 correlate with neovascularization in human carotid atherosclerotic plaques - a pilot study.

Journal: Frontiers in immunology

Published: January 19, 2026

Oral Eikenella as a potential new biomarker of symptomatic carotid atherosclerosis.

Oral Eikenella as a potential new biomarker of symptomatic carotid atherosclerosis.

Journal: Journal of oral microbiology

Published: January 15, 2026

The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial.

The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial.

Journal: EBioMedicine

Published: May 23, 2025

Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long-Term Cardiovascular Mortality.

Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long-Term Cardiovascular Mortality.

Journal: Journal of the American Heart Association

Published: January 27, 2025

Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination.

Altered amyloid plasma profile in patients with disabling headaches after SARS-CoV-2 infection and vaccination.

Journal: BMJ neurology open

Published: December 21, 2024

The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial.

The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial.

Journal: Frontiers in immunology

Published: November 21, 2024

Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis.

Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis.

Journal: JACC. Advances

Published: October 25, 2024

Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis.

Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis.

Journal: JACC. Advances

Published: October 25, 2024

IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.

IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement.

Journal: The Journal of infection

Published: March 01, 2024

Relationship between fibroblast growth factor in plasma and carotid plaque neovascularization: a pilot study.

Relationship between fibroblast growth factor in plasma and carotid plaque neovascularization: a pilot study.

Journal: Frontiers in immunology

Published: February 12, 2024

Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study.

Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study.

Journal: Frontiers in immunology

Published: January 31, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026